HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Clausen Selected Research

Cyclophosphamide (Cytoxan)

6/2023Adverse impact of a high CD4/CD8 ratio in the allograft may be overcome by methotrexate- but not mycophenolate- or post-transplant cyclophosphamide-based graft versus host disease prophylaxis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Clausen Research Topics

Disease

4Neoplasms (Cancer)
10/2010 - 02/2000
3Multiple Sclerosis
04/2001 - 03/2001
1Graft vs Host Disease (Graft-Versus-Host Disease)
06/2023
1Pain (Aches)
07/2017
1Proteinuria
07/2009
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
06/2007
1Type 2 Diabetes Mellitus (MODY)
08/2004
1Insulin Resistance
08/2004
1Breast Neoplasms (Breast Cancer)
08/2001
1Genetic Predisposition to Disease (Genetic Predisposition)
04/2001

Drug/Important Bio-Agent (IBA)

2AntigensIBA
06/2007 - 07/2001
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2023
1Methotrexate (Mexate)FDA LinkGeneric
06/2023
1Sirolimus (Rapamycin)FDA Link
07/2009
1KIR ReceptorsIBA
06/2007
1LigandsIBA
06/2007
1Insulin (Novolin)FDA Link
08/2004
12,4-thiazolidinedione (thiazolidinedione)IBA
08/2004
1LipidsIBA
08/2004
1Lipoproteins (Lipoprotein)IBA
08/2004
1Glyburide (Glibenclamide)FDA LinkGeneric
08/2004
1Pioglitazone (Actos)FDA Link
08/2004
1Paclitaxel (Taxol)FDA LinkGeneric
08/2001
1Epirubicin (Ellence)FDA LinkGeneric
08/2001
1Cytotoxins (Cytolysins)IBA
07/2001
1Monoclonal AntibodiesIBA
07/2001
1Radioisotopes (Radionuclides)IBA
07/2001
1HLA Antigens (Human Leukocyte Antigens)IBA
04/2001
1NucleotidesIBA
04/2001
13' Untranslated Regions (3' UTR)IBA
04/2001
1HLA-DR15 antigenIBA
04/2001
1MHC class II transactivator proteinIBA
04/2001
1CTLA-4 AntigenIBA
03/2001
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2000

Therapy/Procedure

3Drug Therapy (Chemotherapy)
08/2001 - 02/2000
2Transplantation
07/2017 - 08/2001
1Therapeutics
10/2010
1Stem Cell Transplantation
10/2010
1Hematopoietic Stem Cell Transplantation
07/2009
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
06/2007
1Autologous Transplantation
08/2001
1Immunotherapy
07/2001